Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Sarah Grillo/Axios

The COVID Tracking Project, a volunteer group of data analysts, researchers, and journalists brought together by The Atlantic, published its final daily update on Monday — the first anniversary of its founding.

Why it matters: The project quickly became a vital resource for news media, academic researchers, and everyday Americans to track COVID-19 cases, hospitalizations, and deaths in the absence of reliable and public data from the federal government.

Where it stands: Eric Kissane and Alexis Madrigal, co-founders of the project, point to the release of hospitalization data from the Health and Human Services Department, the CDC's vaccine tracker, and county-level testing data from the CDC as evidence that transparency from the government has improved enough to justify winding down the project.

By the numbers: In its final update, the COVID Tracking Project said that states had reported 1.2 million tests, 41,265 new cases, 40,212 total hospitalizations, and 839 deaths.

What they're saying: "We began the work out of necessity and planned to do it for a couple of weeks at most, always in the expectation that the federal public health establishment would make our work obsolete," Kissane and Madrigal said in a February blog post.

  • "Every few months through the course of the project, we asked ourselves whether it was possible to wind down. Instead, we saw the federal government continue to publish patchy and often ill-defined data while our world-famous public health agencies remained sidelined and underfunded, their leadership seemingly inert."
  • "Although substantial gaps and complexities remain, we have seen persuasive evidence that the CDC and HHS are now both able and willing to take on the country’s massive deficits in public health data infrastructure and to offer the best available data and science communication in the interim."

Madrigal, a journalist at The Atlantic, pointed to two reasons for the new "encouraging signs" in a February NPR interview.

  • "I mean, I think the Trump administration was actively suppressing some of the information that the federal government had. That's one piece," he said. Multiple reports suggested deep politicization of the Trump administration's coronavirus response.
  • "And the second piece is just that it took a while to get the data systems online at the federal level to produce the kind of data that you would need to respond to and understand the pandemic," Madrigal added.

What's next: A full archive for data released by the project is under construction, while analysis and tips on where to find sources to replace CTP will be published until May.

Go deeper

Chauvin trial leaves cities, activists across America on edge

Illustration: Brendan Lynch/Axios

The impact of the Derek Chauvin trial is reverberating far beyond the walls of the downtown Minneapolis courtroom.

The state of play: With the trial set to enter its third week, activists across America are watching the proceedings unfold with heavy skepticism that what they perceive as justice will be served.

Felix Salmon, author of Capital
1 hour ago - Economy & Business

The dispiriting housing boom

Illustration: Sarah Grillo/Axios

It's a discouraging scene: Bidding wars, soaring prices, and fears that homeownership is becoming out of reach for millions of Americans. We're in a housing frenzy, driven by a massive shortage of inventory — and no one seems to be happy about it.

Why it matters: Not all bubbles burst. Real estate, in particular, tends to rise in value much more easily than it falls. Besides, says National Association of Realtors chief economist Lawrence Yun, this "is not a bubble. It is simply lack of supply."

Updated 5 hours ago - World

China's COVID vaccines have low efficacy rates, official says

China Centers for Disease Control director Gao Fu at a March event in Beijing, China. Photo: Han Haidan/China News Service via Getty Images

The Chinese Center for Disease Control and Prevention's director said Saturday authorities are considering mixing COVID-19 vaccines because the country's domestically made doses "don't have very high protection rates," per AP.

Why it matters: The remarks by the Gao Fu at a news conference in the southwestern city of Chengdumark mark the first time a Chinese health official has spoken publicly about the low efficacy of vaccines made in China.